GBA Variants and Parkinson Disease: Mechanisms and Treatments
L Smith, AHV Schapira - Cells, 2022 - mdpi.com
The GBA gene encodes for the lysosomal enzyme glucocerebrosidase (GCase), which
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
maintains glycosphingolipid homeostasis. Approximately 5–15% of PD patients have …
[HTML][HTML] New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)
CP Palanisamy, JJ Pei, P Alugoju, NVA Anthikapalli… - Theranostics, 2023 - ncbi.nlm.nih.gov
Neurodegenerative diseases are characterized by the progressive loss of neurons and
intricate interactions between different cell types within the affected regions. Reliable …
intricate interactions between different cell types within the affected regions. Reliable …
More than meets the eye in Parkinson's disease and other synucleinopathies: from proteinopathy to lipidopathy
M Flores-Leon, TF Outeiro - Acta neuropathologica, 2023 - Springer
The accumulation of proteinaceous inclusions in the brain is a common feature among
neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD), and …
neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease (PD), and …
[HTML][HTML] Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
ME Gegg, E Menozzi, AHV Schapira - Neurobiology of Disease, 2022 - Elsevier
Dysfunction of the endolysosomal system is implicated in the pathogenesis of both sporadic
and familial Parkinson disease (PD). Variants in genes encoding lysosomal proteins have …
and familial Parkinson disease (PD). Variants in genes encoding lysosomal proteins have …
The consequences of GBA deficiency in the autophagy–lysosome system in Parkinson's disease associated with GBA
E Pradas, M Martinez-Vicente - Cells, 2023 - mdpi.com
GBA gene variants were the first genetic risk factor for Parkinson's disease. GBA encodes
the lysosomal enzyme glucocerebrosidase (GBA), which is involved in sphingolipid …
the lysosomal enzyme glucocerebrosidase (GBA), which is involved in sphingolipid …
The GBA variant E326K is associated with alpha-synuclein aggregation and lipid droplet accumulation in human cell lines
LJ Smith, MM Bolsinger, KY Chau… - Human Molecular …, 2023 - academic.oup.com
Sequence variants or mutations in the GBA gene are numerically the most important risk
factor for Parkinson disease (PD). The GBA gene encodes for the lysosomal hydrolase …
factor for Parkinson disease (PD). The GBA gene encodes for the lysosomal hydrolase …
Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
LJ Smith, CY Lee, E Menozzi, AHV Schapira - Frontiers in Neurology, 2022 - frontiersin.org
Variants in the GBA1 and LRRK2 genes are the most common genetic risk factors
associated with Parkinson disease (PD). Both genes are associated with lysosomal and …
associated with Parkinson disease (PD). Both genes are associated with lysosomal and …
Contribution of autophagy-lysosomal pathway in the exosomal secretion of alpha-synuclein and its impact in the progression of Parkinson's disease
D Sepúlveda, M Cisternas-Olmedo, J Arcos… - Frontiers in Molecular …, 2022 - frontiersin.org
Parkinson's disease (PD) is caused by the degeneration of dopaminergic neurons due to an
accumulation of intraneuronal abnormal alpha-synuclein (α-syn) protein aggregates. It has …
accumulation of intraneuronal abnormal alpha-synuclein (α-syn) protein aggregates. It has …
Dry eye in Parkinson's disease: a narrative review
In Parkinson's disease (PD) patients, a wide range of ocular and visual disorders are
present. Tear film instability, inflammation and dysfunction of the ocular surface, and the …
present. Tear film instability, inflammation and dysfunction of the ocular surface, and the …
[HTML][HTML] Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases
M Izco, E Carlos, L Alvarez-Erviti - Neurobiology of Disease, 2022 - Elsevier
Although the factors contributing to the pathogenesis of neurodegenerative diseases remain
elusive, endolysosomal pathway is emerging as a key player in the pathogenesis of …
elusive, endolysosomal pathway is emerging as a key player in the pathogenesis of …